Pharmaceuticals TechnologyTaj Pharmaceuticals Limited’s manufacturing strengths
Taj Pharmaceuticals Limited’s rapid growth and expansion in the international and domestic markets led to the commencement of a new formulations manufacturing facility at Baddi, Himachal Pradesh, in the last quarter of 2005-06. The upcoming facility, built to world-class standards, will have capacity to manufacture 2100 mn tablets and shall become operational in JN 08.
Investment of around 2.35 million USD is also being made to augment the API capacity in Taj Pharmaceuticals Limited’s existing plant at Maharashtra .This will ensure supply of quality API for supply of formulations to the regulated markets, especially USA and EU.
An organisations’ capabilities and intent are strongly reflected in the product it manufactures. In other words, the manufacturing competencies and facilities echo truly, the R&D extent and the ability to implement it for the best of the market it targets.
Taj Pharmaceuticals Limited’s manufacturing strengths have established it as a producer of world-class generics, branded generics and a major supplier of its range of Active Pharmaceutical Ingredients. Taj Pharmaceuticals Limited has world-class manufacturing facilities in seven countries namely China, Ireland, India, Malaysia, Nigeria, USA and Vietnam. Its overseas facilities are designed to cater to the requirements of the local regulatory bodies of that country while the Indian facilities meet the requirements of all International Regulatory Agencies. Some of the agencies such as MCA-UK, MCC-Sout Africa, FDA-USA and TGA-Australia, have audited and approved Taj Pharmaceuticals Limited’s manufacturing facilities for the compliance with international. Good Manufacturing Practices and have registered its products for safety, quality and efficacy. Taj Pharmaceuticals Limited exports raw materials, intermediates, prescription drugs, OTC products and veterinary products. Taj Pharmaceuticals Limited also offers technology for products and processes. Technical know-how/fees received during the year 2004-05 amounted to Rs.415 million. Taj Pharmaceuticals Limited's manufacturing facilities have been approved by the following regulatory authorities:
Food and Drug Administration (FDA), USA
Medicines and Healthcare products Regulatory Agency (MHRA), UK
Therapeutic Goods Administration (TGA), Australia
Medicines Control Council (MCC), South Africa
National Institute of Pharmacy (NIP), Hungary
Pharmaceutical Inspection Convention (PIC), Germany
World Health Organization (WHO)
Department of Health, Canada
State Institute for the Control of Drugs, Slovak Republic
|Manufacturing Capacities ::||Formulation Qty. in Million|
|Gard Gelatin Capsules||
|Soft Gelatin Capsules||
|Drysterilf Injectables (Freeze Dried)||
Taj Pharamceuticals Limited is a company selling research medicines herb worldwide. The combination of the GMP certified to manufacture Indian herbal medicine and GMP certified to produce western medicine gives this company has the capabilities and has further strengthened the Golden Pharma Pvt. Ltd. Company's resources, and has given the company the ability to offer the quality products and create innovative solutions for new products development.